PAM
RYTM icon

Panagora Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Panagora Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-64,614
Closed -$6.53M – 1252
2025
Q3 		$6.53M Sell
64,614
-54,852
-46% -$5.09M 0.03% 329
2025
Q2 		$7.55M Sell
119,466
-21,696
-15% -$1.33M 0.03% 292
2025
Q1 		$7.48M Buy
+141,162
New +$7.83M 0.04% 289

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Panagora Asset Management's RYTM Position: Q4 2025 in Review

Panagora Asset Management sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2025, closing a stake of 64,614 shares — an estimated $6.53M sold.

Panagora Asset Management first reported a position in RYTM in Q1 2025 and held it in 3 quarters. The position peaked at $7.55M in Q2 2025. 280 funds tracked by Wall St. Rank hold RYTM as of Q4 2025.

  • Panagora Asset Management reported no remaining Rhythm Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Panagora Asset Management sold 64,614 Rhythm Pharmaceuticals shares in Q4 2025, an estimated $6.53M.
  • Panagora Asset Management first reported a position in Rhythm Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • Panagora Asset Management's Rhythm Pharmaceuticals position peaked at $7.55M in Q2 2025.
  • 280 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2025.

Based on Panagora Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.